Rjs, you are waaay smarter than most of us on this topic. Do you not think that, given what we are told/have seen about the safety of our vaccine, identifying the correct formulation of the peptides that have the correct mechanism to attach to the virus on one of the 9 safe (vs 1791 unsafe) attachment points on the virus is a huge step forward?
Am I wrong that this is what we expect to have after the peptide/blood testing results are released?
I know the trials are still a huge set of hurdles, but my take has been that the proper identification of what will be trialed is a particularly important step here due to a confidence in the science (vs mRNA, etc).
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links